Merck & Co. shares slipped after the pharmaceutical giant issued annual guidance below market expectations, citing Trump-era drug price cuts and patent expirations.
#YonhapInfomax #Merck #AnnualGuidance #DrugPriceCuts #EarningsPerShare #PatentExpiration #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=103670
#YonhapInfomax #Merck #AnnualGuidance #DrugPriceCuts #EarningsPerShare #PatentExpiration #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=103670
